ATNM
Actinium Pharmaceuticals Inc
1.10$
-3.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 96.2% | 96.1% | 96.6% | 96.9% | 96.8% | 96.9% | 96.8% | 96.8% | 96.8% | 95.4% | 95.2% | 94.0% | |
| 93.3% | 94.1% | 95.1% | 95.7% | 95.8% | 94.8% | 95.2% | 95.1% | 95.1% | 92.7% | 92.7% | 90.8% | |
| 93.3% | 94.1% | 95.1% | 95.7% | 95.8% | 94.8% | 95.2% | 95.1% | 95.1% | 92.7% | 92.7% | 90.8% | |
| 51.0% | 55.3% | 50.4% | 51.2% | 53.5% | 57.4% | 62.6% | 69.8% | 75.5% | 84.9% | 94.9% | 24.5% | |
| 9.7% | 10.4% | 9.1% | 10.8% | 9.4% | 10.6% | 10.4% | 13.2% | 12.2% | 15.4% | 16.2% | 23.1% | |
| 0.6% | 0.7% | 0.6% | 0.6% | 0.7% | 0.8% | 0.9% | 1.0% | 1.1% | 1.4% | 1.6% | 1.9% | |
| 9.2% | 9.8% | 8.5% | 10.2% | 8.8% | 9.8% | 9.5% | 12.2% | 11.1% | – | 14.6% | 21.2% | |
| 49.0% | 44.7% | 49.6% | 48.8% | 46.5% | 42.6% | 37.4% | 30.2% | 24.5% | 15.1% | 5.1% | 75.5% | |
| -369.1% | -414.5% | -391.9% | -398.0% | -449.6% | -488.7% | -570.7% | -632.6% | -719.1% | -791.3% | -913.8% | -964.5% | |
| 30.4% | 33.9% | 31.6% | 33.5% | 37.8% | 40.6% | 45.4% | 49.5% | 55.6% | 60.3% | 68.7% | 78.2% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.